Relmada Therapeutics Inc
F:4E2
Relmada Therapeutics Inc
F:4E2
Price:
3.26
EUR
3.16%
Market Cap:
€98.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
M
|
MEP Corporation PCL
SET:MEB
|
TH |
|
A
|
Advanced Micro Devices Inc
XMUN:AMD
|
US |
|
C
|
Coca-Cola Co
F:CCC3
|
US |
|
I
|
Imperial Brands PLC
SWB:ITB
|
UK |
|
V
|
Varonis Systems Inc
SWB:VS2
|
US |
|
F
|
Fluor Corp
F:FLU
|
US |
|
C
|
Canadian Natural Resources Ltd
F:CRC
|
CA |
|
F
|
Fairvest Ltd
JSE:FTB
|
ZA |
|
W
|
Woolworths Group Ltd
F:WWR
|
AU |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
Covivio SA
F:F5D
|
FR |
DCF Value
The DCF Value for 
Relmada Therapeutics Inc (4E2) under the Base Case is hidden
EUR.
Compared with the current market price of 3.26 EUR, the stock appears hidden
.
Key assumptions
Relmada Therapeutics Inc DCF Value
LOCKED
DCF Model
DCF Assumptions
Model Settings
Valuation Result
DCF Value per Share
LOCKED
·
